Skip to main content
Home

Breadcrumb

  1. Home
  2. Pharma

Pharma

17 January 2023

TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies. Cellul...

15 November 2022

Global Mutual brings forward ‘Riverlabs’, the most affordable fitted wet laboratory space at the heart of the Golden Triangle

14 November 2026

Being successful while being yourself: play to your strengths,not to a role

Discover your authentic style of being successful in your career. When we start out, many of us learn “habits and perspective” we supposedly need to adapt in order to be successful. ...

12 January 2023

Arecor announces transfer of AT307 to Hikma

License milestone to develop and commercialise ready-to-use medicine achieved. Arecor regains rights to AT282 following portfolio review at Hikma. ...

19 December 2022

Rare Disease: A year in review

As more investments have been made in developing and commercializing treatments for rare diseases, the experience and expertise of our CRA teams have grown. The number of client projects undertaken by CRA consultants in rare diseases now exceeds 600 in the last five years and constitute...

30 November 2022

Charles River Associates (CRA) Acquires bioStrategies Group, Inc.

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing  ...

10 January 2023

2023: a new year with a renewed focus for the Guardtech Group

Cleanroom construction specialists’ multi-faceted approach set to reach new levels and new audiences in 2023. ...

4 January 2023

Spatial lung cell atlas offers insights into disease and immune function

The most comprehensive lung cell atlas to date, from the Wellcome Sanger Institute and collaborators, has revealed 11 new lung cell types and offers detailed insight into an immune process involved in fighting lung infections. ...

16 December 2022

EPSRC-funded software for research communities project to position OpenMM community at forefront of latest CADD developments

A recent EPSRC application in support of a more sustainable, community-driven development model of OpenMM. ...

15 December 2022

Cresset shares December 2022 newsletter

The Cresset December 2022 newsletter features Dr Robert Scoffin's CEO end of year message, and radial plots in Flare and Spark. ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 100
  • Page 101
  • Current page 102
  • Page 103
  • Page 104
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS